← Leaderboards
Haian Fu
Emory University
$16,783,892
Attributed
$17,816,691
Total exposure
16
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$75,156,513 · 20
By mechanism
U54$36,581,016 · 1
P50$12,550,270 · 4
U01$12,012,449 · 3
P01$9,423,251 · 4
R01$3,518,089 · 3
P30$962,785 · 3
Top collaborators
- Suresh S Ramalingam9 shared
- Aled M Edwards5 shared
- Allan I Levey5 shared
- Frank M Longo5 shared
- Gregory W Carter4 shared
- Stephen Vernon Frye3 shared
- Opher Gileadi3 shared
- Lara M Mangravite3 shared
Most similar at Emory University
Same institution · by research overlap
- Jack L Arbiser$5,737,275
- Rama Rao Amara$90,840,294
- Dipali Sharma$3,976,187
- Raymond F. Schinazi$18,319,973
- Stefan G Sarafianos$26,943,765
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsMalignant NeoplasmsResearch PersonnelTumorCollaborationsNovel TherapeuticsInnovationMolecularBiologyBaseDrug DiscoveryMemberLeadFundingPathway InteractionsUniversitiesTechnologyResearch Clinical TestingCancer TherapySmall MoleculeCancer PatientResourcesMalignant Neoplasm Of LungTargeted Treatment
Grant awards (79)
Discovery of Antivirals Targeting Mpox Virus$767,057
R01 · FY2025 · AI
Discovery and Developmental Therapeutics Research Program$258,891
P30 · FY2025 · CA · contact PI
Deciphering LKB1-associated immunotherapy resistance in lung adenocarcinoma (LUAD)$2,055,632
P01 · FY2024 · CA · contact PI
Administrative Supplement: Interim Funding for Emory Lung Cancer SPORE$896,274
P50 · FY2024 · CA
Discovery of Antivirals Targeting Mpox Virus$782,142
R01 · FY2024 · AI
Project 2: Reversing STING-mediated immunosuppression in LKB1-mutant lung adenocarcinoma$415,518
P01 · FY2024 · CA · contact PI
Core 1: Administration$148,750
P01 · FY2024 · CA · contact PI
Developmental Research Program$128,039
P50 · FY2024 · CA · contact PI
Discovery and Developmental Therapeutics Research Program$59,398
P30 · FY2024 · CA · contact PI
Open Drug Discovery Center for Alzheimer's Disease$7,132,571
U54 · FY2023 · AG
Deciphering LKB1-associated immunotherapy resistance in lung adenocarcinoma (LUAD)$2,164,833
P01 · FY2023 · CA · contact PI
Emory University Lung Cancer SPORE$1,839,911
P50 · FY2023 · CA
Project 2: Reversing STING-mediated immunosuppression in LKB1-mutant lung adenocarcinoma$390,089
P01 · FY2023 · CA · contact PI
Core 1: Administration$159,419
P01 · FY2023 · CA · contact PI
Developmental Research Program$76,785
P50 · FY2023 · CA · contact PI
Discovery and Developmental Therapeutics Research Program$57,939
P30 · FY2023 · CA · contact PI
Open Drug Discovery Center for Alzheimer's Disease$7,217,536
U54 · FY2022 · AG
Deciphering LKB1-associated immunotherapy resistance in lung adenocarcinoma (LUAD)$2,229,253
P01 · FY2022 · CA · contact PI
Emory University Lung Cancer SPORE$1,839,911
P50 · FY2022 · CA
Project 2: Reversing STING-mediated immunosuppression in LKB1-mutant lung adenocarcinoma$394,856
P01 · FY2022 · CA · contact PI
Core 1: Administration$166,782
P01 · FY2022 · CA · contact PI
Developmental Research Program$97,025
P50 · FY2022 · CA · contact PI
Discovery and Developmental Therapeutics$57,188
P30 · FY2022 · CA · contact PI
Open Drug Discovery Center for Alzheimer's Disease$7,311,958
U54 · FY2021 · AG
Emory University Lung Cancer SPORE$1,825,119
P50 · FY2021 · CA
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation$932,391
U01 · FY2021 · CA · contact PI
Developmental Research Program$89,776
P50 · FY2021 · CA · contact PI
Discovery and Developmental Therapeutics$82,644
P30 · FY2021 · CA · contact PI
Open Drug Discovery Center for Alzheimer's Disease$7,420,073
U54 · FY2020 · AG
Emory University Lung Cancer SPORE$1,865,070
P50 · FY2020 · CA
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation$932,722
U01 · FY2020 · CA · contact PI
Developmental Research Program$91,922
P50 · FY2020 · CA · contact PI
Discovery and Developmental Therapeutics$82,644
P30 · FY2020 · CA · contact PI
Open Drug Discovery Center for Alzheimer's Disease$7,498,878
U54 · FY2019 · AG
Emory University Lung Cancer SPORE$1,853,913
P50 · FY2019 · CA
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation$905,028
U01 · FY2019 · CA · contact PI
Developmental Research Program$89,809
P50 · FY2019 · CA · contact PI
Discovery and Developmental Therapeutics$82,644
P30 · FY2019 · CA · contact PI
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation$933,288
U01 · FY2018 · CA · contact PI
Discovery and Developmental Therapeutics$82,644
P30 · FY2018 · CA · contact PI
Discovery and Developmental Therapeutics$13,364
P30 · FY2018 · CA · contact PI
Discovery and Developmental Therapeutics$4,861
P30 · FY2018 · CA · contact PI
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation$791,318
U01 · FY2017 · CA · contact PI
Discovery and Developmental Therapeutics$50,360
P30 · FY2017 · CA · contact PI
High Throughput Protein-Protein Interaction Interrogation in Cancer$860,078
U01 · FY2016 · CA · contact PI
DISCOVERY AND DEVELOPMENTAL THERAPEUTICS PROGRAM$28,108
P30 · FY2016 · CA · contact PI
High Throughput Protein-Protein Interaction Interrogation in Cancer$860,078
U01 · FY2015 · CA · contact PI
HIGH THROUGHPUT PROTEIN-PROTEIN INTERACTION INTERROGATION IN CANCER$860,078
U01 · FY2015 · CA · contact PI
DISCOVERY AND DEVELOPMENTAL THERAPEUTICS PROGRAM$28,108
P30 · FY2015 · CA · contact PI
High Throughput Protein-Protein Interaction Interrogation in Cancer$834,276
U01 · FY2014 · CA · contact PI
HIGH THROUGHPUT PROTEIN-PROTEIN INTERACTION INTERROGATION IN CANCER$834,276
U01 · FY2014 · CA · contact PI
DISCOVERY AND DEVELOPMENTAL THERAPEUTICS PROGRAM$25,019
P30 · FY2014 · CA · contact PI
High Throughput Protein-Protein Interaction Interrogation in Cancer$808,473
U01 · FY2013 · CA · contact PI
HIGH THROUGHPUT PROTEIN-PROTEIN INTERACTION INTERROGATION IN CANCER$808,473
U01 · FY2013 · CA · contact PI
DISCOVERY AND DEVELOPMENTAL THERAPEUTICS PROGRAM$22,395
P30 · FY2013 · CA · contact PI
DISCOVERY AND DEVELOPMENTAL THERAPEUTICS PROGRAM$2,339
P30 · FY2013 · CA · contact PI
High Throughput Protein-Protein Interaction Interrogation in Cancer$825,985
U01 · FY2012 · CA · contact PI
HIGH THROUGHPUT PROTEIN-PROTEIN INTERACTION INTERROGATION IN CANCER$825,985
U01 · FY2012 · CA · contact PI
DISCOVERY AND DEVELOPMENTAL THERAPEUTICS PROGRAM$24,239
P30 · FY2012 · CA · contact PI
DEVELOPMENT OF NOVEL CURCUMIN ANALOGS FOR THE TREATMENT OF HEAD AND NECK CANCER$332,688
P50 · FY2011 · CA · contact PI
DEVELOPMENT OF NOVEL CURCUMIN ANALOGS FOR THE TREATMENT OF HEAD AND NECK CANCER$373,491
P50 · FY2010 · CA · contact PI
Targeting 14-3-3-Mediated Survival$312,133
P01 · FY2010 · CA · contact PI
DEVELOPMENT OF NOVEL CURCUMIN ANALOGS FOR THE TREATMENT OF HEAD AND NECK CANCER$402,982
P50 · FY2009 · CA · contact PI
Targeting 14-3-3-Mediated Survival$279,658
P01 · FY2009 · CA · contact PI
DEVELOPMENT OF NOVEL CURCUMIN ANALOGS FOR THE TREATMENT OF HEAD AND NECK CANCER$401,830
P50 · FY2008 · CA · contact PI
Targeting 14-3-3-Mediated Survival$271,666
P01 · FY2008 · CA · contact PI
DEVELOPMENT OF NOVEL CURCUMIN ANALOGS FOR THE TREATMENT OF HEAD AND NECK CANCER$345,725
P50 · FY2007 · CA · contact PI
Targeting 14-3-3-Mediated Survival$269,130
P01 · FY2007 · CA · contact PI
Targeting 14-3-3-Mediated Survival$165,532
P01 · FY2006 · CA · contact PI
Structure and Function of 14 3 3 Proteins$258,084
R01 · FY2005 · GM
AlphaScreen Technology for High Throughput Screenin(RMI)$4,590
R03 · FY2005 · MH
Structure and Function of 14 3 3 Proteins$272,925
R01 · FY2004 · GM
Structure and Function of 14 3 3 Proteins$272,925
R01 · FY2003 · GM
CONTROL OF APOPTOSIS SIGNAL-REGULATING KINASE (ASK) 1$212,800
R01 · FY2003 · GM
Structure and Function of 14 3 3 Proteins$311,656
R01 · FY2002 · GM
CONTROL OF APOPTOSIS SIGNAL-REGULATING KINASE (ASK) 1$212,800
R01 · FY2002 · GM
CONTROL OF APOPTOSIS SIGNAL-REGULATING KINASE (ASK) 1$213,267
R01 · FY2001 · GM
CONTROL OF APOPTOSIS SIGNAL-REGULATING KINASE (ASK) 1$214,433
R01 · FY2000 · GM
STRUCTURE AND FUNCTION OF 14 3 3 PROTEINS$104,063
R29 · FY2000 · GM